Aimeike Technology Development Co., Ltd., ifresh, a well-known hyaluronic acid brand in China, focuses on the research and development, production and operation of dermal filler products for skin and plastic surgery

Evelet is currently the first to obtain CFDA certification in China, containing lidocaine for injection modified sodium hyaluronate gel. It is a popular hyaluronic acid replacement product. Evelet's unique and exclusive "soothing technology", the product is specially added with the soothing and pain-relieving formula Lidocaine, which significantly reduces the pain during your injection, doubles your comfort during injection, saves your time in the injection room, and makes beauty more enjoyable.

The main ingredients of Evelay are sodium hyaluronate (extracted by microbial fermentation), lidocaine hydrochloride, and sodium chloride phosphate buffer solution. It undergoes a unique cross-linking technology to form modified sodium hyaluronate, which is injected into the subcutaneous area for filling. The addition of lidocaine hydrochloride can reduce the pain of the injection process.

Product contraindications: patients with immune dysfunction and immune diseases; Those with scar constitution; Those who are allergic to hyaluronic acid; Pregnant and lactating women; Persons under the age of 18; The long-acting product has been injected at the injection site, or the short-acting product has not been metabolized; The injection site is in the active phase of infection; People who are allergic to lidocaine.